Key result
The diagnosis of acute congestive heart failure is improved by integrating routine clinical evaluation with serum B-type natriuretic peptide and intrathoracic impedance.
Why the study?
What are the optimal clinical approaches and tools for diagnosing acute heart failure?
What are the optimal clinical approaches and tools for diagnosing acute heart failure?
This review highlights that while traditional clinical evaluation is foundational for diagnosing acute heart failure, biomarkers like BNP and novel tools like intrathoracic impedance provide significant additive diagnostic value.
May support multimodal acute HF diagnosis; leaves open prospective validation before practice change.
PURPOSE OF REVIEW: Predicting which patients with congestive heart failure will decompensate is often difficult, and it is often difficult to distinguish congestive heart failure from other causes of acute dyspnea. This review will focus on some of the newer tools used to diagnose acute congestive heart failure in addition to reviewing the utility of more traditional tools. RECENT FINDINGS: The integration of pertinent positives and negatives on a routine history, key physical findings on examination and routine noninvasive imaging offers high positive and negative predictive power for the diagnosis of acute heart failure. Measurement of B-type natriuretic peptide and N-terminal proB-type natriuretic peptide offers additional and incremental diagnostic information. Measurement of intrathoracic impedance is a novel and potentially useful tool to track absolute changes in cardiac function and total lung fluid content, and may be useful for the outpatient titration of medical therapy to minimize acute congestive heart failure decompensation. SUMMARY: Consistent accurate diagnosis of decompensated congestive heart failure is possible using no more than a complete history and physical examination along with routine imaging techniques. The ability to diagnose acute congestive heart failure however, is improved by using serum B-type natriuretic peptide and intrathoracic impedance, both of which offer additive and complementary diagnostic information.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2007) conducted a review in Acute heart failure. Diagnostic tools (natriuretic peptides and intrathoracic impedance) was evaluated. The diagnosis of acute congestive heart failure is improved by integrating routine clinical evaluation with serum B-type natriuretic peptide and intrathoracic impedance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: